Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00037505 · ClinicalTrials.gov registry record
Major Depression and Inflammatory Risk Markers for Coronary Heart Disease
A clinical trial of Depression, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- 1
- Study location
NCT00037505: Completed study of Depression, sponsored by National Center for Research Resources (NCRR).
NCT00037505 is a study of Depression that has completed, run by National Center for Research Resources (NCRR). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00037505, a study of Depression, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- 1
- Study location
Study Summary
The overall purpose of this research is to examine whether depression influences immune system function. Studies indicate that individuals who are depressed experience coronary heart disease at a higher rate than expected. This study's goal is to begin identifying mechanisms that might be responsible for this process. This research also examines whether behavioral processes (e.g. smoking) or hormonal processes (e.g. adrenaline release) are responsible for immune system differences between depressed and nondepressed people
Conditions Studied
Study Locations (1)
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|
What the finished NCT00037505 record still lists
NCT00037505 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 0 interventions.
NCT00037505 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT00037505 about?
NCT00037505 is a clinical study titled "Major Depression and Inflammatory Risk Markers for Coronary Heart Disease". The overall purpose of this research is to examine whether depression influences immune system function. Studies indicate that individuals who are depressed experience coronary heart disease at a higher rate than expected. This study's goal is to begin identifying mechanisms that might be responsibl...
What is the current status of trial NCT00037505?
This trial is currently completed.
What conditions does trial NCT00037505 study?
This clinical trial studies the following conditions: Depression.
Who is sponsoring clinical trial NCT00037505?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00037505 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4